BeiGene, Ltd. Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BeiGene, Ltd. for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 3.49 | 28,600 | 99,814 | 947,965 | |
| May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 3.49 | 3,900 | 13,611 | 976,565 | |
| May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 130.06 | 2,200 | 286,132 | 0 | 2.2 K to 0 (-100.00 %) |
| May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 45.31 | 2,200 | 99,682 | 2,200 | 0 to 2.2 K |
| May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 130.12 | 300 | 39,036 | 0 | 300 to 0 (-100.00 %) |
| May 22 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 45.31 | 300 | 13,593 | 300 | 0 to 300 |
| May 22 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 301,600 | 150,800 | 4,120,000 | |
| May 22 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 130.21 | 23,200 | 3,020,860 | 0 | 23.2 K to 0 (-100.00 %) |
| May 22 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 23,200 | 150,800 | 23,200 | 0 to 23.2 K |
| May 15 2019 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 125.11 | 15,027 | 1,880,028 | 0 | 15 K to 0 (-100.00 %) |
| May 08 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 23,400 | 11,700 | 4,421,600 | |
| May 08 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 130.01 | 1,800 | 234,014 | 0 | 1.8 K to 0 (-100.00 %) |
| May 08 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 1,800 | 11,700 | 1,800 | 0 to 1.8 K |
| May 02 2019 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 125.55 | 113 | 14,187 | 17,365 | 17.5 K to 17.4 K (-0.65 %) |
| May 02 2019 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 124.48 | 5,657 | 704,153 | 17,478 | 23.1 K to 17.5 K (-24.45 %) |
| May 02 2019 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 125.43 | 185 | 23,205 | 23,135 | 23.3 K to 23.1 K (-0.79 %) |
| May 02 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 126.54 | 51 | 6,454 | 0 | 51 to 0 (-100.00 %) |
| May 02 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 125.53 | 1,371 | 172,101 | 51 | 1.4 K to 51 (-96.41 %) |
| May 02 2019 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 124.79 | 1,402 | 174,950 | 1,422 | 2.8 K to 1.4 K (-49.65 %) |